UnknownNot Applicable

The Response of the Immune System of Patients With End Stage Kidney Disease on Dialysis and Kidney Transplant Recipients Vaccinated for COVID-19

Greece100 participantsStarted 2021-04-24

Plain-language summary

Observational study of patients with End Stage Kidney Disease on dialysis and Kidney Transplant Recipients, before and after vaccination for SARS-COV 2, after written consent, with the aim of laboratory efficacy of the vaccine and safety regarding the clinical outcome of patients and possible complications.

Who can participate

Age range18 Years – 90 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age \>18 years * Covid 19 vaccination Exclusion Criteria: * previous covid infection * recent infection * chronic infection * HBV, HCV, HIV * Active malignancy

What they're measuring

Efficacy of the vaccine

Timeframe: 24 months

Trial details

NCT IDNCT04932876

SponsorUniversity of Ioannina

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2021-12

Contact for this trial

Evangelia Ntounousi, PHD

+302651007429 edounous@uoi.gr

View on ClinicalTrials.gov More End Stage Kidney Disease trials